GlassScriptPhysician profile
Devony A Webster Hitt
NPI 1679771604
$4,284.95
in general payments reported to CMS, 2019-2025
36 companies · $857 in 2025
The $857 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $424 · 2022: $887 · 2023: $904 · 2024: $1,212 · 2025: $857.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,974.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $923.50 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $594.78 | 2021-2025 | Airsupra, Farxiga, Wainua |
| Novo Nordisk INC | $561.05 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Axsome Therapeutics, INC. | $305.17 | 2025 | Auvelity |
| Lilly USA, LLC | $304.27 | 2022-2024 | Mounjaro, Jardiance |
| Pfizer INC. | $178.45 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $173.05 | 2022-2025 | Xifaxan, Trulance |
| Abbott Laboratories | $162.95 | 2021-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $129.65 | 2024-2025 | Caplyta |
| Amgen INC. | $112.98 | 2022-2024 | Repatha, Otezla, Evenity |
| Otsuka America Pharmaceutical, INC. | $98.73 | 2023-2024 | Rexulti |
| Janssen Pharmaceuticals, INC | $79.79 | 2021 | |
| Novartis Pharmaceuticals Corporation | $47.10 | 2024 | |
| Esperion Therapeutics, INC. | $41.61 | 2024 | Nexletol |
| Merck Sharp & Dohme LLC | $41.32 | 2022-2023 | Belsomra |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $40.09 | 2022-2023 | Quviviq |
| Antares Pharma, INC. | $39.41 | 2022 | |
| Verity Pharmaceuticals INC. | $38.75 | 2024 | Tlando |
| Boston Scientific Corporation | $35.66 | 2021 | |
| Genentech USA, INC. | $33.03 | 2021 | |
| Exact Sciences Corporation | $31.50 | 2023-2024 | Cologuard Collection Kit |
| Pacira Pharmaceuticals Incorporated | $31.16 | 2024 | Iovera, Zilretta |
| Pacira Therapeutics, INC. | $28.46 | 2021 | |
| Djo, LLC | $28.31 | 2025 | Cmf |
| Curonix LLC | $23.71 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Glaxosmithkline, LLC. | $23.28 | 2024 | Shingrix, Arexvy |
| Biogen, INC. | $22.93 | 2024 | Skyclarys |
| Bausch Health US, LLC | $21.92 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $19.81 | 2023 | Livalo |
| Nevro Corp. | $19.79 | 2023 | Senza |
| Amarin Pharma, INC. | $19.79 | 2021 | |
| Medtronic, INC. | $15.91 | 2024 | Kyphon Express II Kyphopak Tray |
| Paratek Pharmaceuticals, INC. | $15.69 | 2024 | Nuzyra |
| Vertex Pharmaceuticals Incorporated | $14.30 | 2025 | |
| Bioventus LLC | $14.19 | 2025 | Exogen Ultrasound Bone Healing System |
| E.R. Squibb & Sons, L.L.C. | $12.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devony Webster Hitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.